ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Attum, A. A.
Right arrow Articles by Lansing, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Attum, A. A.
Right arrow Articles by Lansing, A. M.

The Annals of Thoracic Surgery, Vol 44, 217-222, Copyright © 1987 by The Society of Thoracic Surgeons


ARTICLES

Malignant clinical behavior of cardiac myxomas and "myxoid imitators"

AA Attum, GS Johnson, Z Masri, R Girardet and AM Lansing

The clinical experience with cardiac myxomas and "myxoid imitators" at the Humana Heart Institute International is reviewed and contrasted with a comprehensive review of the world literature. Twenty-two patients with primary cardiac tumors have been treated at our institution. Three (13.6%) of them had myxoid imitators, and 19 had classic myxomas. One of the 19 patients with a classic myxoma had recurrence on two occasions (recurrence rate, 5.3%). The cases of 57 patients from the world literature are reviewed. Recurrence and/or metastases (including formation of mycotic aneurysm) occurred in approximately 50% of these patients. The overall mortality in these patients was 47%. This review provides documentation of the malignant clinical behavior of cardiac myxomas and myxoid imitators. Neither local recurrence nor regrowth of the tumor in a new location, whether intracardiac or extracardiac, can be predicted from the microscopic appearance of the primary tumor. Resection of the myxoma with a wide margin is the recommended surgical procedure but does not ensure a cure. Therefore, long-term follow-up is mandatory.


This article has been cited by other articles:


Home page
Card Surg AdultHome page
J.-C. M. Walkes, W. R. Smythe, and M. J. Reardon
Cardiac Neoplasms
Card. Surg. Adult, January 1, 2008; 3(2008): 1479 - 1510.
[Full Text]


Home page
ICVTSHome page
L.-M. Stevens, H. Lapierre, M. Pellerin, I. El-Hamamsy, D. Bouchard, M. Carrier, and L. P. Perrault
Atrial versus biatrial approaches for cardiac myxomas
Interactive CardioVascular and Thoracic Surgery, December 1, 2003; 2(4): 521 - 525.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
M. J. Reardon and W. R. Smythe
Cardiac Neoplasms
Card. Surg. Adult, January 1, 2003; 2(2003): 1373 - 1400.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
F. Bernet, P. M. Stulz, and T. P. Carrel
Long-term remission after resection, chemotherapy, and irradiation of a metastatic myxoma
Ann. Thorac. Surg., November 1, 1998; 66(5): 1791 - 1792.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1987 by The Society of Thoracic Surgeons.